Wright Pushes FTC For More Pay-For-Delay Study

Law360, New York (October 1, 2013, 6:25 PM EDT) -- In the wake of the U.S. Supreme Court's pay-for-delay ruling, the Federal Trade Commission should do more research to develop evidence that might allow lower courts to presume certain types of pharmaceutical patent settlements are anti-competitive, Commissioner Joshua Wright said Thursday.

Even though the justices refused to endorse the FTC's bid for such a presumption in their June decision, the ruling left the door open for lower courts to develop those types of presumptions down the road, Wright said in a speech.

"A case-specific presumption could...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.